← 返回事件
持续讨论商业

Eli Lilly is buying a biotech startup for nearly $3 billion to expand into autoimmune diseases

图:Quartz

发生了什么

The deal adds a pipeline targeting the antibodies behind Graves' disease, thyroid eye disease, food allergy, and other conditions

摘要按规则整理自下方来源原文

来源